| Financial Year |
March 31 2023 |
| Monetary Funds |
221,149,236.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,617,660.47 |
| Accounts Receivable |
290,355,935.84 |
| Advances to Suppliers |
12,703,053.59 |
| Other Receivables |
35,538,030.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
138,163,997.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,518,184.79 |
| Total Current Assets |
762,498,343.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,062,579.58 |
| Long-term Equity Investment |
9,860,690.62 |
| Investment Properties |
89,670,603.90 |
| Fixed Assetes |
701,513,486.83 |
| Under-construction Projects |
305,801,834.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
244,086,150.47 |
| R&D expenses |
98,815,897.52 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,916,086.86 |
| Deferred Income Tax Assets |
15,232,682.85 |
| Other Non-Current Assets |
196,850,032.80 |
| Sub-Total of Non-Current Assets |
1,792,061,731.78 |
| Total Assets |
2,554,560,074.91 |
| Short-Term Loans |
163,169,209.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
253,145,893.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,803,251.37 |
| Taxes Payable |
30,628,676.72 |
| Interest Payable |
-- |
| Dividend Payable |
515,771.00 |
| Other payables |
110,766,026.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,106,456.62 |
| Other Current Liabilities |
11,951,696.58 |
| Sub-Total of Current Liabilities |
601,945,196.31 |
| Long-term Loans |
446,058,788.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
18,429,732.88 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,437,346.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
617,909,158.76 |
| Total Liabilities |
1,219,854,355.07 |
| Paid-In Capital(Or Share Stock) |
502,483,396.00 |
| Capital Surplus |
134,749,471.19 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
57,947,775.00 |
| Undistributed Profits |
708,775,713.61 |
| Minority Stockholder's Interest |
46,644,914.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,288,060,805.80 |
| Owner's Equity（Stockholder's Equity） |
1,334,705,719.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,554,560,074.91 |
